Much like Pfizer, Merck (NYSE: MRK) has had a couple of unprofitable quarters on an operational basis recently, though it also has more than 30 programs in phase 3 clinical trials, at least some of ...

These blue chip dividend stocks would be ideal for investors who had to hold them forever. They provide reliable streams of ...

Pfizer (NYSE: PFE) is a pharmaceutical stock that needs no introduction -- or perhaps ... Much like Pfizer, Merck (NYSE: MRK) has had a couple of unprofitable quarters on an operational basis ...

Among those partners are the prominent industry players Bristol-Myers Squibb Co. (BMY), Merck & Co. Inc. (MRK) and Astellas ... MSFT needs no introduction among tech investors.

Merck (MRK) reachead $106.64 at the closing of the latest trading day, reflecting a +0.28% change compared to its last close. Visa, Netflix, Merck and Hovnanian are included in this Analyst Blog.

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

In this article, we will look at where Merck & Co. Inc. (NYSE:MRK) ranks among the most undervalued quality stocks to buy according to analysts. Despite global uncertainties, the US economy is ...

Merck & Co Inc. (NYSE:MRK) delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. It has a strong focus on research and ...